Navigation Links
In Terms of Effect on Overall Survival, Current and Emerging Therapies Have No Advantage Over Avastin/FOLFIRI in the Treatment of Second-Line Metastatic Colorectal Cancer, According to Clinical Data and Thought Leader Opinion
Date:7/15/2013

cond-line therapies for metastatic colorectal cancer are another important consideration in oncologists' prescribing decisions, as the incidence of colorectal cancer increases with age and, as a result, therapies in this setting have a great impact on the quality of life in an elderly population.  

The report also finds that surveyed managed care organization (MCO) pharmacy directors are receptive to novel therapies that offer an improvement in median overall survival over currently available therapies, but while some emerging therapies hold promise, they are unlikely to match payers' requirements for widespread inclusion on their formularies.

"Avastin in combination with FOLFIRI is currently the most widely used regimen for the second-line treatment of metastatic colorectal cancer," said Decision Resources Business Insights Analyst Dana Gheorghe, Ph.D. "An emerging therapy like ramucirumab will find it difficult to penetrate the already crowded second-line market, given physicians' familiarity with Avastin. However, if ramucirumab can show competitive advantages in efficacy, and safety in Phase III trials, we believe it has the potential to compete strongly following its anticipated launch in 2015."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Accelerate Diagnostics Announces Final Terms of Rights Offering
2. Cancer Vaccine Partnering Terms and Agreements
3. Medstrat Posts Documents Confirming Terms Of Dismissal Of Merges Lawsuit
4. On-Demand Reports on Partnering Terms in Healthcare & Pharma Sectors: New Market Research at ReportsnReports.com
5. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
6. Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinsons Blood Test Joint Venture
7. Sonendo Agrees To Terms For Up To $20 Million In Financing
8. Vaccine Partnering Terms and Agreements
9. Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
10. Side Effects Limit Prescription Drug Compliance
11. CHPA Applauds Pennsylvanias Adoption of Real-Time, Stop-Sale Technology, An Effective Tool in the Fight Against Methamphetamine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 4, 2015 A ... of hypertension, diabetes and thyroid disorders in Central and ... educational platforms and a major conference dedicated to these ... Manage Diabetes Online , Manage Hypertension Online ... developed and operated by EXCEMED - combine ...
(Date:7/3/2015)... NEW YORK , July 3, 2015  Obsidian ... ) - an online service for the management of ... professionals announced today that PharmaShine now includes the 2014 ... Center for Medicare Services on June 30. The data ... 11.4 million transactions between industry and providers totaling $6.49 ...
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ... today that its common shares have been approved for listing ... symbol "EPIX". ESSA will begin trading on NASDAQ ... on the TSX Venture Exchange under the symbol "EPI". ... shares on the NASDAQ, each of the Company,s outstanding special ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4
... April 21 BioMarin Pharmaceutical Inc. (Nasdaq: ... 1/2 clinical trial for BMN-110 or N-acetylgalactosamine 6-sulfatase (GALNS), ... Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. ... the first half of 2010. "We plan to ...
... studies; Data to be presented at AACR - ... and development company Esperance Pharmaceuticals today presented positive ... support the initiation of clinical trials in cancer. ... Cationic Lytic Peptide (CLYP(TM)) platform technology. EP-100 is ...
Cached Medicine Technology:BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome 2BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome 3BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome 4First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 2First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 3
(Date:7/3/2015)... ... 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... will reveal biblical truth and expose popular lies regarding proper relationships according to the ... Sex”, immediately goes into the core of the subject by explaining why certain types ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... New Albany, MS 38652, will have a grand opening event on July 4, 2015 ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on June 22, ... emphatically declared a war on obesity in the United States. , "Obesity is one ... the magnitude of this discovery. For that reason, I am declaring, along with my ...
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly Tech Report, ... technology expert and special reporter for NewsWatch, conducted the review and shared with viewers ... , According to the U.S. Department of Energy, it’s very important to use energy-efficient ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... for embryonic development can quickly become a potent cancer promoter ... from Fox Chase Cancer Center, causing white blood cells to ... the journal Cancer Research, the researchers detail how a gene ... drive cancer in mice. The protein that Dlx5 encodes could ...
... leave nation vulnerable to disease, bioterror and health, threats according to ... ... Public Health, WASHINGTON, Feb. 27 While natural disasters,the threat ... resources, the U.S. is facing a major public health,workforce crisis that could ...
... 27 Riverview Medical,Center, located in Red ... under the J.D. Power and Associates Distinguished ... by Riverview,Medical Center to provide an "outstanding ... ), The service excellence distinction was ...
... Vaccination Programs Using FluMist(R) May Serve as Model ... Help Vaccinate Large Numbers of Eligible ... MedImmune, the manufacturer,of FluMist(R) (Influenza Virus Vaccine Live, ... and Prevention,s (CDC) Advisory Committee,on Immunization Practices (ACIP) ...
... to health care might help to overcome racial and ethnic ... the March 2008 issue of Clinical Journal of the American ... "yet another wake-up call as to how we as a ... nation, including the reduction and/or elimination of health disparities," according ...
... KAN. -- Despite millions of dollars spent on food safety ... to E. coli O157:H7 were higher in 2007 than in ... Texas A&M University. E. coli O157:H7 has been linked to ... , "We have been studying the effects of a novel ...
Cached Medicine News:Health News:Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 3Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 2Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 3Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 2Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 3Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 4Health News:Race, insurance status affect access to transplantation and kidney disease treatment 2Health News:Race, insurance status affect access to transplantation and kidney disease treatment 3Health News:Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle 2
... is an easy-to-use, automated system that enables ... assays for managing hemostatic disordersincluding D-Dimer, Von ... offers reflex and rerun testing for greater ... by our high-quality service to help your ...
... Embolic Protection System is designed to provide ... when performing carotid stenting interventions. The ACCUNET ... system that utilizes rapid exchange technology so ... filter during catheter manipulations. It is available ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
Medicine Products: